CSBR · Champions Oncology Inc
United States · RS rating 24 · As of 2026-10-14
| Price | 4.81 USD |
|---|---|
| 1-day change | -1.8% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 75 / 21 / 23 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 16 / 8 |
| Industry group (rank) | Medical-Research Eqp/Svc (31) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +10.1% |
| Distance from 52-week high | +38.3% |
| Market cap (USD) | $83.9M |